- MustGrow and Sumitomo expand their biopesticide program
- Results of US field trials are positive as efficacy was comparable to leading synthetic chemical standards
- Sumitomo will develop the mustard plant-derived biopesticide in the Americas
- MustGrow is an agriculture biotech company
- MustGrow (MGRO) is up 8.82 per cent at C$3.95 at 12:42 PM EST
MustGrow (MGRO) and Sumitomo have expanded their biopesticide program following positive US field trials.
Together they are expanding into multiple countries and new crop categories.
Sumitomo conducted field trials of MustGrow’s mustard plant-derived biopesticide technology. Efficacy was comparable to leading synthetic chemical standards.
Sumitomo is preparing to commercialize the mustard-derived biopesticide in Colombia. Sumitiomo will also expand development work in Mexico, Peru, and Chile of MustGrow’s technology.
The companies are commencing regulatory approval processes in multiple countries across South and Central America in addition to the ongoing US Environmental Protection Agency approval process.
COO of MustGrow, Colin Bletsky commented about the partnership.
“The US field trial performance with Sumitomo Corporation’s team continues to show that our technology works with potential application techniques in many different crop categories and geographies.”
Head of Business Development, Marcos Mares, said,
“Developing sustainable crop protection products with MustGrow in the Americas offers a tremendous opportunity and responsibility to help growers tackle some of the key issues facing them and the world today.”
MustGrow is an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops.
Sumitomo is a diversified multinational corporation and one of the world’s largest general trading companies.
MustGrow (MGRO) is up 8.82 per cent at C$3.95 at 12:42 PM EST.